BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 15.08.2025

FDA Announces Public Workshop on Advancing Interchangeable Biosimilar Products

The FDA is hosting a public workshop to discuss and identify future needs for interchangeable biosimilar products, as part of its commitment to the Biosimilar User Fee Act reauthorization.

Source: Federal Register — Food and Drug AdministrationOpen original release →